Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Form 483
Manufacturing
Novo plant acquired in Catalent deal lands in FDA's crosshairs
Novo has received an FDA Form 483 at the Indiana facility after an agency inspection of the site in late June and July, Stat first reported.
Fraiser Kansteiner
Aug 22, 2025 10:49am
Eli Lilly confirms plan to sell New Jersey plant
Aug 4, 2025 10:50am
China biotech deals, Takeda, LaNova—Fierce Pharma Asia
Jul 18, 2025 9:04am
Trump's tariffs, Leqembi, Kyowa Kirin—Fierce Pharma Asia
Apr 18, 2025 9:25am
Aurobindo discloses FDA Form 483 at North Carolina inhaler plant
Apr 14, 2025 3:00pm
Eisai, ex-NMPA official, Pfizer-Summit—Fierce Pharma Asia
Feb 28, 2025 8:45am
